# Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device

> **NCT04753112** · PHASE3 · COMPLETED · sponsor: **Germans Trias i Pujol Hospital** · enrollment: 14 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Sacubitril / Valsartan Oral Tablet [Entresto]

## Key facts

- **NCT ID:** NCT04753112
- **Lead sponsor:** Germans Trias i Pujol Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-29
- **Primary completion:** 2021-09-08
- **Final completion:** 2021-09-20
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04753112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04753112, "Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04753112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*